|
| |
Overview
Financial Highlight
HeadlinesNo recent Headlines for this stock. Business Background StemLife Berhad (StemLife) is a blood stem cell banking and storage services provider. StemLife is engaged in the stem cell therapy and stem cell consultancy services; collection, testing, processing and preservation of umbilical cord blood stem cells; testing, processing and preservation of blood stem cells, and investment holding. The Company's subsidiaries include Stemlife Properties Sdn. Bhd., which is a investment holding company; Stemlife Therapeutics Sdn. Bhd., which is engaged in harvesting, testing, processing and preservation of peripheral blood stem cells, and Stemlife Logistics Sdn. Bhd, which is engaged in logistics of umbilical cord blood stem cells and blood stem cells. On December 21, 2010, the Company acquired Stemvet Sdn. Bhd., being a subsidiary of Stemlife Therapeutics Sdn. Bhd. also became a wholly owned subsidiary of Stemlife Berhad 27% interest in Stemlife Therapeutics Sdn. Bhd.
  stoptakingmyusername good qr result, this stock will trend up a while before profit taking.. tp: 43 11/11/2015 8:37 AM  birkincollector oh my,,,,,,,,45sen so low and close to current price, no excitement tmr!! 12/11/2015 7:23 PM  snwong13 StemLife Receives Takeover Offer At RM0.45 Per Share Stem cell banking company StemLife has received a mandatory takeover offer from its major shareholder, Singapore-listed Cordlife Group, to acquire the remaining 67 percent stake it does not own in the company for RM0.45 per share. The take-over offer was triggered after Cordlife, already a major shareholder of firm, crossed the 33 percent threshold with the purchase of 3 million shares or 1.2 percent of the company on 12 November. Other notable shareholders in StemLife include Berjaya Corporation (10 percent) and JP Morgan Chase (4.6 percent). The company has said that its board will hold a meeting to deliberate the offer and make an announcement in due course. Significance: The offer price of RM0.45 represents a RM0.025 or 5.9 percent premium against StemLife’s closing price of RM0.425 on 12 November. It was noted that Cordlife does not intend to maintain the listing status of the firm if the all-cash offer, which is worth RM1.4 billion, goes through. 14/11/2015 10:30 AM hoplanner What's the rationale for buying above offer price RM0.45? Are these buyers going to reject the offer? 04/12/2015 10:52 PM drkschua59 Do not sell this counter. Cordlife has bigger plans but want it cheap. The regenerative industry is starting to pick up. The assets of this company is substantial,cash and real estate. The business is still profitable. If not Cordlife would not buy. 06/12/2015 5:53 PM hoplanner CordLife has been buying @o.45 in open market to ensure its takeover bid wld be successful. This C9 has good potential to grow exponentially. Look at TMC, the share wld be 50 sen easily if it is still listed.....provided all who have faith in this Co reject the 0.45 offer. 06/12/2015 9:20 PM drkschua59 Look at Japan, the govt. is supporting their Regenerative Medicine industry. They are buying biotech companies dealing with stem cells. Even Mesoblast of Australia is going to Japan get their products commercially available. Cordlife is doing well making profits and expanding in Asia. So you think they will lose money in Stemlife?? They want to buy cheap lah. The reg med industry will definitely grow in the near future. 07/12/2015 9:17 AM AmstrongKL I strongly agreed with drkschua59. The reg med industry is the future, either near term or long term. But, I will make sure the management team is trustworthy & sincere in doing businesses. There are too many conman management in KLSE. Must be very careful. 08/12/2015 11:22 AM  foodie http://www.thestar.com.my/business/business-news/2015/12/08/cordlifes-takeover-offer-for-stemlife-turns-unconditional/?style=biz 08/12/2015 7:36 PM drkschua59 The present board of directors is definitely more professionally qualified. Except I don't know whether they are more loyal to Cordlife or dedicated to rejunavate Stemlife. The business is ongoing and the staff are working hard. One client of cord tissue banking is worth 3 of cord blood. I hope they cannot gather enough shares to take it private. I want the board to give more back to loyal shareholders. The board have not explained to the sharehokders why it is so important to take it private. Perhaps they want to enrich Cordlife and themselves. They should offer in exchange some cordlife shares. 08/12/2015 7:49 PM drkschua59 If Stemlife is still listed, 3 years is the minimum. There is no other counter that deals with stem cells and hence no competitor. TMC does NOT have any stem cell business anymore. 09/12/2015 4:59 PM NG Jack sorry im newbie here, what do you mean if is still listed? If i get in the train tomorrow, and privatise no more listing, what will impact on us as share holder? 09/12/2015 8:33 PM richcares if privatise, you will get a pay check depending on the amount of shares you have. You will not want to hold shares in a privatise company 10/12/2015 9:21 AM NG Jack will we be notified if company being privatise? Is there a chances that company pay lower than share market price? 10/12/2015 3:19 PM NG Jack good or bad news? :) http://www.prnewswire.co.uk/news-releases/biosafe-and-stemlife-sign-a-long-term-supply-agreement-561378141.html 10/12/2015 3:38 PM drkschua59 Basically Stemlife is here to stay for a long time. As i have said Cordlife sees great future but they want it all for themself. Taking it private also mean doing a lot more without having to face both the shareholders and the securities commission. More can be achieved this way and when they want to cash out again, they relist when the situation is much better ie when regenerative medicine industry is booming. 10/12/2015 5:19 PM MMCP PUBLIC SHAREHOLDINGS SPREAD STEMLIFE BERHAD Type Announcement Subject PUBLIC SHAREHOLDINGS SPREAD Description StemLife Berhad ("StemLife" or "The Company") Non-compliance with Public Shareholding Spread pursuant to Rule 8.02(1) of the ACE Market Listing Requirements ("LR") of Bursa Malaysia Securities Berhad ("Bursa Securities") We refer to the announcements dated 22 December 2015, 23 December 2015 and 28 January 2016 and 11 February 2016 (“Earlier Announcements”). Unless otherwise stated, all definitions and terms used in this announcement shall have the same meaning as stated in the Earlier Announcements in relation to the Public Shareholdings Spread. The Board of Directors wishes to announce that the Company will be applying to Bursa Securities for an extension of time in order to implement the necessary procedures to withdraw its listing status from the Official List of Bursa Securities in accordance with Chapter 16 of the LR. This announcement is dated 16 February 2016. 17/02/2016 2:28 PM dompeilee Wat lar...this company not yet taken over completely...no more AGM??? 48c Q-ing to buy many lots no sellers, including me who holds on tight to my shares :D 27/05/2016 2:27 PM dompeilee When is the cheapskate Cordlife going to raise its takeover price to 50c??? 14/06/2016 1:18 PM ML46 Anyone still holding this share? What happen if you don't take up the offer? 30/12/2016 8:37 PM  | |
